14 results
8-K
EX-99.1
ARCT
Arcturus Therapeutics Holdings Inc
4 Mar 20
Arcturus Therapeutics and Duke-NUS Medical School Partner to Develop a Coronavirus (COVID-19) Vaccine using STARR TechnologyTM
8:52am
in the fight against COVID-19, developing the first serological tests for COVID-19 and was among the first groups to isolate and culture the virus
8-K12B
ARCT
Arcturus Therapeutics Holdings Inc
14 Jun 19
Notification of registration of securities
5:10pm
with a very successful track record in entrepreneurship. She has a true passion for creating a winning corporate culture of innovation and expertise
8-K
EX-14.1
ARCT
Arcturus Therapeutics Holdings Inc
13 Dec 21
Arcturus Therapeutics Appoints Jing Marantz, M.D., Ph.D., M.B.A. to its Board of Directors
5:17pm
Partner”), is expected to create a respectful workplace culture that is free of harassment, intimidation, bias and unlawful discrimination
10-K
2019 FY
ARCT
Arcturus Therapeutics Holdings Inc
16 Mar 20
Annual report
11:09am
, we have developed an ex-vivo slice culture technique to treat human lungs with a LUNAR- mRNA encoding green fluorescent protein (LUNAR-eGFP mRNA … ). Effective delivery of the mRNA was demonstrated in these slice cultures of non-CF (Figure D).
Figure D: Slice culture of human lungs treated with LUNAR
DEF 14A
kw4irt s3skoapyvsz0
1 Oct 19
Definitive proxy
6:07am
DEFR14A
p28byb2n g8yis
12 May 22
Revised proxy
5:00pm
S-4
zbubppdl7ppg
15 Mar 19
Registration of securities issued in business combination transactions
9:35pm
424B3
v8rgub5n5ff28 i9g1t2
12 Apr 19
Prospectus supplement
4:39pm
S-4/A
tuk6t7ykumd275e8
11 Apr 19
Registration of securities issued in business combination transactions (amended)
5:26pm
- Prev
- 1
- Next